Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia

May 1, 2016, 00:00
10.1016/j.jval.2016.03.1552
https://www.valueinhealthjournal.com/article/S1098-3015(16)01620-X/fulltext
Title : Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01620-X&doi=10.1016/j.jval.2016.03.1552
First page : A143
Section Title : Cancer - Cost Studies
Open access? : No
Section Order : 269
Categories :
Tags :
Regions :
ViH Article Tags :